Aveed’s Impact on Erythropoiesis in American Males: A Two-Year Study
Reading Time: 2 minutes Introduction Aveed, a testosterone undecanoate injection developed by Endo Pharmaceuticals, is primarily used to treat conditions associated with low testosterone levels in men. Recent studies have begun to explore its broader physiological effects, particularly on erythropoiesis—the process of red blood cell production. This article delves into a two-year hematological study conducted on American males to assess the impact of Aveed on erythropoiesis, shedding light on its potential implications for men's health. Study Design and Methodology The study involved a cohort of 200 American males aged between 30 and 65 years, all of whom were diagnosed with hypogonadism and were candidates...


